創傷性腦損傷評估和管理設備市場－全球產業規模、佔有率、趨勢、機會及預測（按設備、技術、最終用途、地區和競爭格局分類，2021-2031年）

全球創傷性腦損傷評估和管理設備市場預計將從 2025 年的 37.8 億美元成長到 2031 年的 57.6 億美元，複合年成長率為 7.27%。

此市場領域涵蓋用於評估和管理由外部衝擊引起的顱內創傷的診斷設備和治療系統，其主要產品線包括顱內壓監測器、先進的神經影像設備和標靶溫度管理解決方案。推動這一成長的關鍵因素包括全球道路交通事故頻繁、人口老化導致跌倒相關損傷增加，以及運動相關腦震盪通訊協定的加強，這些因素都促使人們對精準的現場評估設備的需求日益成長。

然而，由於輕度腦損傷普遍未被診斷，市場面臨許多障礙，常常導致醫療干預延誤，並限制了設備的普及。這種認知不足嚴重阻礙了診斷技術在重症監護環境之外的應用。根據美國腦損傷協會的數據，到2025年，81%的美國成年人將無法辨識腦震盪屬於創傷性腦損傷。這種巨大的認知差距阻礙了早期檢測工作，並對評估解決方案的更廣泛應用和推廣構成了重大障礙。

市場促進因素

軍事和國防領域對神經創傷解決方案的日益重視，源於作戰和訓練場景中對快速、即用型評估能力的迫切需求，這成為市場成長的強勁驅動力。國防機構優先採購堅固耐用的攜帶式設備和血清生物標記檢測方法，以有效管理爆炸引起的神經創傷，並減輕人員的長期神經損傷，從而催生了對能夠在標準臨床設施之外可靠運行的技術的需求。根據美國軍事衛生系統於2025年8月發布的《2024年國防部全球創傷性腦損傷統計》報告，2024年現役軍人中新增創傷性腦損傷（TBI）病例18,376例，這進一步證實了國防部門作為早期檢測和管理設備主要採購方的關鍵地位。

同時，政府支持計畫和宣傳宣傳活動正在改變市場格局，促進對輕度創傷性腦損傷的識別，而這些損傷往往被忽視。這些教育措施鼓勵人們識別症狀並尋求醫療救助，從而擴大了符合評估和治療條件的患者群體。根據美國腦損傷協會於2025年3月發布的《2025年腦損傷公眾意識報告》，約40%的美國成年人承認經歷過腦損傷症狀，這表明如果將這些潛在病例納入臨床實踐，將具有巨大的市場潛力。這種積極主動的管理趨勢也反映在職業運動領域。 2025年2月，美國國家美式足球聯盟（NFL）報告稱，加強的安全措施使得2024賽季的腦震盪發生率降至歷史新低，僅182例，證明嚴格的評估通訊協定能夠有效降低受傷風險。

市場挑戰

全球創傷性腦損傷評估和管理設備市場成長的主要障礙之一是輕度腦損傷的普遍漏診。這個問題導致顱內創傷的實際發生率與接受臨床治療的患者人數之間存在顯著差異。當症狀被忽視或未能立即與神經損傷聯繫起來時，患者實際上無法獲得診斷工具和治療系統。因此，評估技術的應用仍主要集中在重症創傷中心，阻礙了市場向基層醫療機構、運動醫學診所和門診復健中心等更易普及的場所擴展。

無法準確識別患者直接抑制了對診斷技術的需求。根據美國腦損傷協會 (BIAA) 2025 年的數據，不到四分之一的美國成年人曾被醫療專業人員詢問過腦損傷史。這種低頻率的臨床訪談表明，許多潛在病例仍未被調查。因此，除非常規篩檢成為常態，否則神經影像和監測設備的下游應用將無法滿足實際的醫療需求，這將直接阻礙該行業製造商的產生收入。

市場趨勢

人工智慧 (AI) 和機器學習在預測分析領域的融合，透過自動識別嚴重的顱內異常，正在變革神經創傷護理。先進的演算法正被整合到診斷流程中，能夠基於影像數據快速檢測和量化腦損傷，從而顯著縮短緊急情況下的治療時間。這項技術進步有助於同時分析各種生物標記和顯像模式，為臨床醫生提供即時、數據驅動的決策支援。例如，2025 年 10 月，Qure.ai 在一份關於其「第 19 項 FDA核准」的新聞稿中宣布，其 qER-CTA 演算法已獲得核准。該演算法是一款 AI 工具，可支援神經重症監護病例的快速分流。這項批准進一步擴展了該公司用於自動檢測顱內出血和急性腦部急症的解決方案套件。

隨著人工智慧技術的進步，攜帶式照護現場診斷設備的廣泛應用，使得創傷性腦損傷（TBI）的評估範圍擴展到了院外環境。這些攜帶式設備能夠對顱內出血進行即時評估，即使在資源匱乏、傳統CT掃描難以進行的環境中，例如偏遠地區或救護車上。透過利用近紅外線光譜等技術，這些設備能夠進行可靠的現場篩檢，並支援快速的患者分診。劍橋大學於2025年7月發表的一篇題為《InfraScanner的性能》的研究論文指出，攜帶式InfraScanner 2000在檢測創傷患者的顱內出血方面，陰性預測值高達94.2%，凸顯了其在無法進行全面神經影像診斷的環境中作為一線分診設備的價值。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球創傷性腦損傷評估與管理設備市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 依設備分類（影像診斷設備（核磁共振造影系統、 X光設備、CT設備等）、監測設備）
  • 透過技術手段（顱內壓監測、腦組織氧分壓（pBrO2））
  • 透過申請（醫院、診斷中心等）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

6. 北美創傷性腦損傷評估與管理設備市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

7. 歐洲創傷性腦損傷評估與管理設備市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

8. 亞太地區創傷性腦損傷評估與管理設備市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

9. 中東和非洲創傷性腦損傷評估和管理設備市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

10. 南美洲創傷性腦損傷評估與管理設備市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進要素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 最新進展

第13章 全球創傷性腦損傷評估與管理設備市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的可能性
• 供應商電力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Integra LifeSciences Corp
• BioDirection Inc
• Nihon Kohden Tokyo Corp
• Compumedics Ltd
• InfraScan Inc
• Oculogica Inc
• RAUMEDIC AG

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Traumatic Brain Injuries Assessment And Management Devices Market is projected to expand from a valuation of USD 3.78 billion in 2025 to USD 5.76 billion by 2031, reflecting a compound annual growth rate of 7.27%. This market sector comprises diagnostic apparatus and therapeutic systems intended to assess and manage intracranial trauma caused by external impact, with key product offerings ranging from intracranial pressure monitors to advanced neuroimaging equipment and targeted temperature management solutions. The primary factors fueling this growth include the escalating global frequency of road traffic accidents and the rising number of fall-related injuries within the aging population, alongside intensified protocols for sports-related concussions that drive the need for accurate on-field assessment instruments.

However, the market faces a substantial hurdle due to the prevalent underdiagnosis of mild brain injuries, a factor that frequently delays medical intervention and restricts device usage. This lack of recognition severely curtails the implementation of diagnostic technologies outside of critical care environments. Data from the Brain Injury Association of America indicates that in 2025, 81% of adults in the United States failed to identify concussions as traumatic brain injuries. This profound gap in awareness obstructs early detection efforts and stands as a significant impediment to the wider adoption and expansion of assessment solutions.

Market Driver

The growing integration of neuro-trauma solutions within military and defense sectors serves as a robust engine for market growth, propelled by the urgent necessity for rapid, field-ready assessment capabilities in combat and training scenarios. Defense entities are emphasizing the procurement of ruggedized handheld units and serum biomarker assays to effectively manage blast-induced neurotrauma and mitigate long-term neurological damage among personnel, creating a demand for technologies that function reliably outside standard clinical facilities. As highlighted by the Military Health System in August 2025, the '2024 DOD Worldwide Numbers for TBI' report documented 18,376 new traumatic brain injury diagnoses among active-duty service members in 2024, confirming the defense sector's pivotal role as a major purchaser of early-detection and management devices.

Concurrently, supportive government programs and public awareness campaigns are transforming the market by enhancing the identification of mild traumatic brain injuries that were previously overlooked. These educational initiatives empower individuals to recognize symptoms and pursue medical care, thereby expanding the patient population eligible for assessment and therapy. According to the Brain Injury Association of America's '2025 Public Perceptions of Brain Injury Report' released in March 2025, nearly four out of ten U.S. adults acknowledged experiencing brain injury symptoms, signaling significant market potential if these latent cases are brought into the clinical fold. This trend toward proactive management is also reflected in professional sports; the NFL reported in February 2025 that stricter safety mandates resulted in a record low of 182 concussions during the 2024 season, proving that rigorous assessment protocols are successfully reducing injury risks.

Market Challenge

A major obstacle obstructing the growth of the Global Traumatic Brain Injuries Assessment and Management Devices Market is the pervasive underdiagnosis of mild brain injuries. This issue establishes a considerable disparity between the actual occurrence of intracranial trauma and the number of patients who receive clinical care; when symptoms are ignored or not immediately linked to neurological trauma, the avenue for employing diagnostic tools and therapeutic systems is effectively closed. As a result, the utilization of assessment technologies remains disproportionately focused in high-acuity trauma centers, preventing the market from extending into primary care facilities, sports medicine clinics, and outpatient rehabilitation centers where broader adoption is possible.

This inability to accurately identify patients directly curbs the demand for diagnostic technologies. Data from the Brain Injury Association of America in 2025 reveals that fewer than one in four adults in the United States reported being questioned by a healthcare provider regarding a history of brain injury. Such a low frequency of clinical inquiry implies that a multitude of potential cases go uninvestigated. Consequently, as long as routine screening remains uncommon, the downstream application of neuroimaging modalities and monitoring devices will fail to match the actual medical necessity, thereby directly impeding revenue generation for manufacturers within this industry.

Market Trends

The incorporation of Artificial Intelligence and Machine Learning for Predictive Analytics is transforming neurotrauma care by automating the recognition of severe intracranial anomalies. Sophisticated algorithms are increasingly being integrated into diagnostic workflows to swiftly detect and quantify brain injuries based on imaging data, substantially shortening the time to treatment for urgent conditions. This technological advancement facilitates the concurrent analysis of various biomarkers and imaging modalities, offering clinicians instant, data-backed decision support. For instance, in October 2025, Qure.ai announced in a press release regarding its '19th FDA Clearance' that it received approval for the qER-CTA algorithm, an AI tool engineered to aid in the rapid triage of neurocritical cases, thereby broadening its suite of solutions for automatically detecting intracranial hemorrhages and acute brain emergencies.

Parallel to these AI developments, the proliferation of Handheld and Point-of-Care Diagnostic Devices is extending the scope of TBI assessment into non-hospital settings. These portable units permit the immediate assessment of intracranial bleeding in resource-constrained environments, such as remote locations or ambulances, where access to conventional computed tomography is limited. By leveraging technologies such as near-infrared spectroscopy, these devices facilitate dependable on-site screening that supports rapid patient triage. As reported by the University of Cambridge in a July 2025 research publication titled 'Performance of the InfraScanner', the handheld InfraScanner 2000 exhibited a negative predictive value of 94.2% for detecting intracranial bleeding in trauma patients, highlighting its value as a frontline triage instrument when comprehensive neuroimaging is inaccessible.

Key Market Players

• Integra LifeSciences Corp
• BioDirection Inc
• Nihon Kohden Tokyo Corp
• Compumedics Ltd
• InfraScan Inc
• Oculogica Inc
• RAUMEDIC AG

Report Scope

In this report, the Global Traumatic Brain Injuries Assessment And Management Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Traumatic Brain Injuries Assessment And Management Devices Market, By Devices

• Imaging Devices (Magnetic Resonance Imaging (MRI) Devices, X-Ray, Computed Tomography, Others)
• Monitoring Devices

Traumatic Brain Injuries Assessment And Management Devices Market, By Technique

• Intracranial pressure monitoring
• Partial pressure of oxygen in brain tissue (pBrO2)

Traumatic Brain Injuries Assessment And Management Devices Market, By End-Use

• Hospitals
• Diagnostic centers
• Others

Traumatic Brain Injuries Assessment And Management Devices Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Traumatic Brain Injuries Assessment And Management Devices Market.

Available Customizations:

Global Traumatic Brain Injuries Assessment And Management Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Traumatic Brain Injuries Assessment And Management Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Devices (Imaging Devices (Magnetic Resonance Imaging (MRI) Devices, X-Ray, Computed Tomography, Others), Monitoring Devices)
  • 5.2.2. By Technique (Intracranial pressure monitoring, Partial pressure of oxygen in brain tissue (pBrO2))
  • 5.2.3. By End-Use (Hospitals, Diagnostic centers, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Traumatic Brain Injuries Assessment And Management Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Devices
  • 6.2.2. By Technique
  • 6.2.3. By End-Use
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Traumatic Brain Injuries Assessment And Management Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Devices
      • 6.3.1.2.2. By Technique
      • 6.3.1.2.3. By End-Use
  • 6.3.2. Canada Traumatic Brain Injuries Assessment And Management Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Devices
      • 6.3.2.2.2. By Technique
      • 6.3.2.2.3. By End-Use
  • 6.3.3. Mexico Traumatic Brain Injuries Assessment And Management Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Devices
      • 6.3.3.2.2. By Technique
      • 6.3.3.2.3. By End-Use

7. Europe Traumatic Brain Injuries Assessment And Management Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Devices
  • 7.2.2. By Technique
  • 7.2.3. By End-Use
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Traumatic Brain Injuries Assessment And Management Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Devices
      • 7.3.1.2.2. By Technique
      • 7.3.1.2.3. By End-Use
  • 7.3.2. France Traumatic Brain Injuries Assessment And Management Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Devices
      • 7.3.2.2.2. By Technique
      • 7.3.2.2.3. By End-Use
  • 7.3.3. United Kingdom Traumatic Brain Injuries Assessment And Management Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Devices
      • 7.3.3.2.2. By Technique
      • 7.3.3.2.3. By End-Use
  • 7.3.4. Italy Traumatic Brain Injuries Assessment And Management Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Devices
      • 7.3.4.2.2. By Technique
      • 7.3.4.2.3. By End-Use
  • 7.3.5. Spain Traumatic Brain Injuries Assessment And Management Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Devices
      • 7.3.5.2.2. By Technique
      • 7.3.5.2.3. By End-Use

8. Asia Pacific Traumatic Brain Injuries Assessment And Management Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Devices
  • 8.2.2. By Technique
  • 8.2.3. By End-Use
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Traumatic Brain Injuries Assessment And Management Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Devices
      • 8.3.1.2.2. By Technique
      • 8.3.1.2.3. By End-Use
  • 8.3.2. India Traumatic Brain Injuries Assessment And Management Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Devices
      • 8.3.2.2.2. By Technique
      • 8.3.2.2.3. By End-Use
  • 8.3.3. Japan Traumatic Brain Injuries Assessment And Management Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Devices
      • 8.3.3.2.2. By Technique
      • 8.3.3.2.3. By End-Use
  • 8.3.4. South Korea Traumatic Brain Injuries Assessment And Management Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Devices
      • 8.3.4.2.2. By Technique
      • 8.3.4.2.3. By End-Use
  • 8.3.5. Australia Traumatic Brain Injuries Assessment And Management Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Devices
      • 8.3.5.2.2. By Technique
      • 8.3.5.2.3. By End-Use

9. Middle East & Africa Traumatic Brain Injuries Assessment And Management Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Devices
  • 9.2.2. By Technique
  • 9.2.3. By End-Use
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Traumatic Brain Injuries Assessment And Management Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Devices
      • 9.3.1.2.2. By Technique
      • 9.3.1.2.3. By End-Use
  • 9.3.2. UAE Traumatic Brain Injuries Assessment And Management Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Devices
      • 9.3.2.2.2. By Technique
      • 9.3.2.2.3. By End-Use
  • 9.3.3. South Africa Traumatic Brain Injuries Assessment And Management Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Devices
      • 9.3.3.2.2. By Technique
      • 9.3.3.2.3. By End-Use

10. South America Traumatic Brain Injuries Assessment And Management Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Devices
  • 10.2.2. By Technique
  • 10.2.3. By End-Use
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Traumatic Brain Injuries Assessment And Management Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Devices
      • 10.3.1.2.2. By Technique
      • 10.3.1.2.3. By End-Use
  • 10.3.2. Colombia Traumatic Brain Injuries Assessment And Management Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Devices
      • 10.3.2.2.2. By Technique
      • 10.3.2.2.3. By End-Use
  • 10.3.3. Argentina Traumatic Brain Injuries Assessment And Management Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Devices
      • 10.3.3.2.2. By Technique
      • 10.3.3.2.3. By End-Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Traumatic Brain Injuries Assessment And Management Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Integra LifeSciences Corp
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. BioDirection Inc
• 15.3. Nihon Kohden Tokyo Corp
• 15.4. Compumedics Ltd
• 15.5. InfraScan Inc
• 15.6. Oculogica Inc
• 15.7. RAUMEDIC AG

16. Strategic Recommendations

17. About Us & Disclaimer